MedPath

Development Study Using Vaginal Tactile Imager

Completed
Conditions
Pelvic Organ Prolapse
Registration Number
NCT01111916
Lead Sponsor
Artann Laboratories
Brief Summary

The objective is to evaluate and optimize tactile imaging technology in evaluation of tissue elasticity parameters in the female pelvis.

Detailed Description

Pelvic organ prolapse affects 40-50% of women in US. This study aims to establish a reliable examination procedure, collect data necessary for assessing the performance of Vaginal Tactile Imaging sensors, assess clinical suitability of interface software and correlate elasticity measurements with clinical examination findings for normal versus prolapse conditions of the female pelvis.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
31
Inclusion Criteria
  1. no evidence of pelvic organ prolapse and no prior pelvic surgery
  2. stage 1 or greater pelvic organ prolapse affecting one or more vaginal compartments
  3. no evidence of pelvic organ prolapse with prior pelvic surgery (with or without the use of graft material)
Exclusion Criteria
  1. patients with active skin infection, tissue breakdown or ulceration
  2. patients with abnormal vaginal anatomy, including vaginal septum, history of vaginal/pelvic radiation, presence of a vaginal tumor or lesion
  3. recent pelvic surgery with less than 3-month interval from surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine whether there is a detectable difference in 3-D elasticity images provided by Vaginal Tactile Imager for the patients with presence or absence of prolapse.1 Year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Princeton Urogynecology

🇺🇸

Princeton, New Jersey, United States

Institute for Female Pelvic Medicine and Reconstructuve Surgery

🇺🇸

Allentown, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath